Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer:: Correlation with microsatellite instability and abnormalities of mismatch repair protein expression

被引:61
作者
Scartozzi, M
Bianchi, F
Rosati, S
Galizia, E
Antolini, A
Loretelli, C
Piga, A
Bearzi, I
Cellerino, R
Porfiri, E
机构
[1] Univ Ancona, Dept Oncol Med & Anat, I-60020 Ancona, Italy
[2] Univ Ancona, Dept Istol Patol, I-60020 Ancona, Italy
关键词
D O I
10.1200/JCO.20.5.1203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The relationship between germ-line mutations of hMSH2 and hMLH1, microsatellite instability (MSI), and loss of DNA mismatch repair (MMR) gene expression were studied to formulate an effective selection protocol for patients with suspected hereditary nonpolyposis colorectal cancer who should be offered genetic testing. Patients and Methods: Patients eligible for germline analysis of hMLH1 and hMSH2 were selected. Tumor specimens were obtained to assess MSI and loss of MMR gene expression. Results: Among 37 patients who participated in the study, two hMSH2 and two hMLH1 missense mutations (11%) were detected, none of which was found in a panel of 60 healthy volunteers. High MSI was found in five tumors (19%) and low MSI in 10 tumors (39%); 12 tumors (46%) were microsatellite stable. Four tumors demonstrated loss of hMLH1, and three tumors demonstrated loss of hMSH2 protein expression. Conclusion: No relationship was found between MMR gene mutations and MSI; low or no MSI was found in the four patients with germ-line mutations, and none of the five patients with high MSI demonstrated abnormalities of MMR genes. On the contrary, loss of hMLH1 or hMSH2 expression was found in the tumors from three of the four patients demonstrating germ-line mutations. These data suggest that germ-line mutations of the MMR gene can occur in people with MSI-negative tumors. Sensitive clinical criteria and the study of MMR gene expression may be useful to identify this subset of patients. (C) 2002 by American Society of Clinical Oncology.
引用
收藏
页码:1203 / 1208
页数:6
相关论文
共 24 条
[1]  
Boland CR, 1998, CANCER RES, V58, P5248
[2]   The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer [J].
Guerrette, S ;
Acharya, S ;
Fishel, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6336-6341
[3]   Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma [J].
Herman, JG ;
Umar, A ;
Polyak, K ;
Graff, JR ;
Ahuja, N ;
Issa, JPJ ;
Markowitz, S ;
Willson, JKV ;
Hamilton, SR ;
Kinzler, KW ;
Kane, MF ;
Kolodner, RD ;
Vogelstein, B ;
Kunkel, TA ;
Baylin, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6870-6875
[4]   SCREENING REDUCES COLORECTAL-CANCER RATE IN FAMILIES WITH HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER [J].
JARVINEN, HJ ;
MECKLIN, JP ;
SISTONEN, P .
GASTROENTEROLOGY, 1995, 108 (05) :1405-1411
[5]   Eukaryotic DNA mismatch repair [J].
Kolodner, RD ;
Marsischky, GT .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (01) :89-96
[6]   Missense mutations in hMLH1 associated with colorectal cancer [J].
Liu, T ;
Tannergård, P ;
Hackman, P ;
Rubio, C ;
Kressner, U ;
Lindmark, G ;
Hellgren, D ;
Lambert, B ;
Lindblom, A .
HUMAN GENETICS, 1999, 105 (05) :437-441
[7]  
Loukola A, 1999, J MED GENET, V36, P819
[8]  
Lynch HT, 1999, J MED GENET, V36, P801
[9]  
Lynch HT, 2000, J CLIN ONCOL, V18, p19S
[10]   Immunohistochemistry for hMLH1 and hMSH2: A practical test for DNA mismatch repair-deficient tumors [J].
Marcus, VA ;
Madlensky, L ;
Gryfe, R ;
Kim, H ;
So, K ;
Millar, A ;
Temple, LKF ;
Hsieh, E ;
Hiruki, T ;
Narod, S ;
Bapat, BV ;
Gallinger, S ;
Redston, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (10) :1248-1255